Durability of insulin degludec plus liraglutide versus insulin glargine U100 as initial injectable therapy in type 2 diabetes (DUAL VIII): a multicentre, open-label, phase 3b, rand... von Aroda, Vanita R, González-Galvez, Guillermo, Grøn, Randi, Halladin, Natalie, Haluzík, Martin, Jermendy, György, Kok, Adri, Őrsy, Petra, Sabbah, Mohamed, Sesti, Giorgio, Silver, Robert

Volltext

Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial von Del Prato, Stefano, Pavo, Imre, Weerakkody, Govinda J, Yang, Zhengyu, Aizenberg, Diego, Wynne, Alan G, Wiese, Russell J, Arora, Samir, Calderon, Rafael B, Butuk, David J, Chaychi, Leila, Curtis, Brian M, Chochinov, Ronald, Chow, Christopher, Cone, Clancy L, Dungan, Kathleen, Gaudiani, Linda, Herandez-Vazquez, Luis, Hsia, Stanley H, Kutner, Mark E, Loy, Juan, Miranda, Francisco G, Oliver, Michael J, Parke, Michael T, Philis-Tsimikas, Athena, Rosenstock, Julio, Sorial, Ehab, Stonesifer, Larry D, Stringam, Stanley, Van, Joanna T, Vazquez-Tanus, Jose B, Reyes, Ramon, Karimjee, Najmuddin, Martin, Earl E, Fraser, Neil J, Bhargava, Anuj, Wynne, Alan G, Billings, Liana, Walsh, Patrick, Shubrook, Jay, Knouse, Albert B, Mayfield, Ronald K, Bitar, Fahed G, de la Cuesta, Carmen, Morales Portillo, Cristobal J, Quesada Charneco, Miguel, Tofe Povedano, Santiago, Vazquez, Luis, Soto Gonzalez, Alfonso, Ciomos, Daniela, Neacsu, Valentina, Stern, Naftali, Sofer, Yael, Sack, Jessica, Tirosh, Amir, Shehadeh, Naim, Darawsha, Mahmud, Skripova, Dasa, Pavleova, Eva, Kubincova, Ludmila, Merciakova, Martina, St-Amour, Eric, Yared, Zeina, Blouin, Francois, Aggarwal, Naresh K, Bajaj, Harpreet, Tailor, Chetna, Egan, Alan, St.Onge, Natasha, Borges, Joao L C, Franco, Denise R, Souza, Filipe D, Russo, Luis Augusto T, Sassone, Sonia A, Steinacher, Andrea, Perez Manghi, Federico C, Orio, Silvia I, Gelersztein, Elizabeth, Fretes, José O, Calella, Pedro R F, Zaidman, Cesar J, Chertkoff, Alejandro, Gonzalez Galvez, Guillermo, Calvo, Cesar G, Sowinski, Dariusz, Jozefowska, Malgorzata, Skokowska, Ewa, Modzelewska, Anna, Gilfillan, Christopher, Morbey, Claire, Kaur, Kamal, Kemp, Laurence, Shea, Antony J, Kunitsyna, Marina A, Ou, Horng-Yih, Chen, Jung-Fu, Hwu, Chii-Min, Doupis, John, Pagkalos, Emmanouil, Mouslech, Zadalla

Volltext

Metabolic dysfunction-associated steatotic liver disease and atherosclerosis von Castillo-Núñez, Yulino, Almeda-Valdes, Paloma, González-Gálvez, Guillermo, Arechavaleta-Granell, María del Rosario

Volltext

Efficacy and safety of dual add‐on therapy with dapagliflozin plus saxagliptin versus glimepiride in patients with poorly controlled type 2 diabetes on a stable dose of metformin:... von Frias, Juan P., Gonzalez‐Galvez, Guillermo, Johnsson, Eva, Maaske, Jill, Testa, Marcia A., Simonson, Donald C., Dronamraju, Nalina, Garcia‐Sanchez, Ricardo, Peters, Anne L.

Volltext

A cross-sectional study on the prevalence of cardiovascular disease in elderly patients with long-term type 2 diabetes mellitus mainly attended in private clinics in Mexico. The CA... von Arenas-León, José L, Morales-Villegas, Enrique C, Cardona-Muñoz, Ernesto G, Alcocer-Gamba, Marco A, Ramirez-Contreras, Juan P, Contreras-Sandoval, Aleida Y, González-Galvez, Guillermo

Volltext

RENACED-DT1: A National Type 1 Diabetes Registry Initiative in Mexico von Faradji, Raquel N., Valenzuela-Lara, Marisol, Vidrio-Velázquez, Maricela, Yepez-Rodríguez, Alicia E., González-Galvez, Guillermo, Sainz de la Maza-Viadero, María E.

Volltext

Natural co‐infection of divergent hepatitis B and C virus homologues in carnivores von Jo, Wendy K., Alfonso‐Toledo, Jorge A., Salas‐Rojas, Monica, Almazan‐Marin, Cenia, Galvez‐Romero, Guillermo, García‐Baltazar, Anahí, Obregón‐Morales, Cirani, Rendón‐Franco, Emilio, Kühne, Arne, Carvalho‐Urbieta, Victor, Rasche, Andrea, Brünink, Sebastian, Glebe, Dieter, Aguilar‐Setién, Álvaro, Drexler, Jan Felix

Volltext

Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin... von Aroda, Vanita R, Rosenstock, Julio, Wysham, Carol, Unger, Jeffrey, Bellido, Diego, González-Gálvez, Guillermo, Takami, Akane, Guo, Hailing, Niemoeller, Elisabeth, Souhami, Elisabeth, Bergenstal, Richard M

Volltext

Glycemic control, treatment and complications in patients with type 1 diabetes amongst healthcare settings in Mexico von Antonio-Villa, Neftali Eduardo, García-Tuomola, Aili, Almeda-Valdes, Paloma, Vidrio-Velázquez, Maricela, Islas-Ortega, Laura, Madrigal-Sanromán, Juan R., Zaballa-Lasso, Carmenmari, Martínez-Ramos-Méndez, Angélica, De la Garza-Hernández, Natalia E., Bustamante-Martínez, Jorge F., González-Galvez, Guillermo, Valadez-Capetillo, Mayra, Sanchez-Ruiz, Karla L., Castillo-Galindo, Carmen, Yepez-Rodríguez, Alicia E., Polanco-Preza, Miguel A., Ceballos-Macías, Jose J., Valenzuela-Montoya, Julio C., Escobedo-Ortiz, Ana R., Ferreira-Hermosillo, Aldo, Rodríguez-Sanchez, Ester, Romero-Zazueta, Alejandro, Miracle-López, Sigfrido, Figueroa-Andrade, Mario H., Faradji, Raquel N.

Volltext

Efficacy of lixisenatide in patients with type 2 diabetes: a post hoc analysis of patients with diverse β-cell function in the GetGoal-M and GetGoal-S trials von Yabe, Daisuke, Ambos, Anu, Cariou, Bertrand, Duvnjak, Lea, Evans, Marc, González-Gálvez, Guillermo, Lin, Jay, Nikonova, Elena V, de Pablos-Velasco, Pedro, Yale, Jean-François, Ahrén, Bo

Volltext

Bartonella Infection in Hematophagous, Insectivorous, and Phytophagous Bat Populations of Central Mexico and the Yucatan Peninsula von Stuckey, Matthew J, Chomel, Bruno B, Galvez-Romero, Guillermo, Olave-Leyva, José Ignacio, Obregón-Morales, Cirani, Moreno-Sandoval, Hayde, Aréchiga-Ceballos, Nidia, Salas-Rojas, Mónica, Aguilar-Setién, Alvaro

Volltext

An analysis of the cost-effectiveness of starting insulin detemir in insulin-naïve people with type 2 diabetes von Home, Philip, Baik, Sei Hyun, Gálvez, Guillermo González, Malek, Rachid, Nikolajsen, Annie

Volltext

Predictive and Explanatory Factors of Change in HbA1c in a 24-Week Observational Study of 66,726 People With Type 2 Diabetes Starting Insulin Analogs von HOME, Philip D, CHUNDUO SHEN, HASAN, Mohammad I, LATIF, Zafar A, CHEN, Jian-Wen, GALVEZ, Guillermo González

Volltext

Pragmatic use of insulin degludec/insulin aspart co-formulation: A multinational consensus statement von Kalra, Sanjay, Latif, Zafar, Comlekci, Abdurrahman, Galvez, Guillermo, Malik, Rached, Pathan, Md, Kumar, Ajay

Volltext

The effectiveness and safety of beginning insulin aspart together with basal insulin in people with type 2 diabetes in non-Western nations: Results from the A1chieve observational... von Home, Philip D., Latif, Zafar A., González-Gálvez, Guillermo, Prusty, Vinay, Hussein, Zanariah

Volltext

Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes von Frías, Juan P, Davies, Melanie J, Rosenstock, Julio, Pérez Manghi, Federico C, Fernández Landó, Laura, Bergman, Brandon K, Liu, Bing, Cui, Xuewei, Brown, Katelyn

Volltext

Consensus on the use of iSGLT2 in the treatment of patients with type 2 diabetes mellitus von Garnica-Cuéllar, Juan C, Lavalle-González, Fernando J, Magaña-Serrano, José A, Almeda-Valdés, Paloma, Cetina-Canto, José A, Chávez-Iñíguez, Jonathan S, Garza-García, Carlos A, González-Chávez, Antonio, González-Gálvez G, Guillermo, Medina-Chávez, Juan H, Pimentel-Morales, Gela, Sánchez-Pedraza, Valentín

Volltext

Safety and efficacy of fimasartan in Mexican patients with grade 1-2 essential hypertension von Cardona-Muñoz, Ernesto G, López-Alvarado, Agustín, Conde-Carmona, Ignacio, Sánchez-Mejorada, Gerardo, Pascoe-González, Sara, Banda-Elizondo, Ramiro G, García-Castillo, Armando, González-Gálvez, Guillermo, Velasco-Sánchez, Raúl G, Vidrio-Velázquez, Maricela, Leiva-Pons, José L, Villeda-Espinosa, Efraín, Guerra-López, Arturo, Esturau-Santalo, Ramón M

Volltext

Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial von Bergenstal, Richard M, Dr, Wysham, Carol, MD, MacConell, Leigh, PhD, Malloy, Jaret, PhD, Walsh, Brandon, PhD, Yan, Ping, PhD, Wilhelm, Ken, MD, Malone, Jim, MD, Porter, Lisa E, MD

Volltext

Dapagliflozin plus Saxagliptin Add-On vs. Glimepiride Add-On to Metformin in Patients with Poorly Controlled Type 2 Diabetes von FRIAS, JUAN P., GONZALEZ-GALVEZ, GUILLERMO, JOHNSSON, EVA K., MAASKE, JILL, PETERS, ANNE

Volltext